Is Fexofenadine + Pseudoephedrine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Fexofenadine + Pseudoephedrine, including Telfast - D (60,120 mg,mg, Film-coated tablet, SAR 18.65).

Is Fexofenadine + Pseudoephedrine approved by the US FDA?

Drugs@FDA lists 11 application product lines for Fexofenadine + Pseudoephedrine, including ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION (Over-the-counter); ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (Over-the-counter); FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (Over-the-counter); FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (Over-the-counter); FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (Over-the-counter).

Active substances

Fexofenadine + Pseudoephedrine

SFDA 1
US FDA 11
Health Canada 1
US price lines 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Telfast - D	60,120 mg,mg	Film-coated tablet · Oral use	10 Blister	SAR 18.65	NCE · OTC	Sanofi Consumer Healthcare	Valid

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION	60MG;120MG	tablet, extended release · oral	CHATTEM SANOFI	Over-the-counter	24 Dec 1997
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	180MG;240MG	tablet, extended release · oral	CHATTEM SANOFI	Over-the-counter	19 Oct 2004
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	180MG;240MG	tablet, extended release · oral	DR REDDYS LABS LTD	Over-the-counter	17 Mar 2010
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	DR REDDYS	Over-the-counter	18 Nov 2014
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	SUN PHARM	Over-the-counter	29 Jan 2015
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	AUROBINDO PHARMA	Over-the-counter	30 Oct 2017
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	DR REDDYS	Over-the-counter	31 May 2022
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	180MG;240MG	tablet, extended release · oral	AUROBINDO PHARMA LTD	Over-the-counter	17 Apr 2025
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	L PERRIGO CO	Over-the-counter	7 Oct 2025
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	BARR	Discontinued	14 Apr 2005
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	60MG;120MG	tablet, extended release · oral	IMPAX PHARMS	Discontinued	12 Nov 2010

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
ALLEGRA-D	02239853	60 MG; 120 MG	TABLET (IMMEDIATE- AND EXTENDED-RELEASE) · ORAL	SANOFI CONSUMER HEALTH INC

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
US NADAC	FEXOFENADINE-PSE ER 60-120 TAB	$0.48321	per EA	23 Sep 2026
US NADAC	GNP FEXOFENADINE-PSE ER 60-120	$0.48321	per EA	23 Sep 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.